Postoperative bleeding associated with antiplatelet and anticoagulant drugs: A retrospective study.


Journal

Oral surgery, oral medicine, oral pathology and oral radiology
ISSN: 2212-4411
Titre abrégé: Oral Surg Oral Med Oral Pathol Oral Radiol
Pays: United States
ID NLM: 101576782

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 29 01 2019
revised: 21 03 2019
accepted: 08 04 2019
pubmed: 20 5 2019
medline: 30 1 2020
entrez: 20 5 2019
Statut: ppublish

Résumé

To examine postoperative bleeding in patients taking antiplatelet and anticoagulant medications after invasive periodontal procedures. This 6-year retrospective study collected data from the electronic health records of patients who underwent invasive periodontal procedures at the College of Dentistry, University of Kentucky Lexington, from January 1, 2011 through April 1, 2017. Records were included when the medical history was current, an invasive periodontal procedure was performed, an antiplatelet or anticoagulant medication was taken, and a postoperative visit was documented. Four hundred and fifty-six patients (age range 22-89 years; mean age 66.1 years; 58% male) met the inclusion criteria and underwent 867 invasive periodontal procedures. Antiplatelet medications, warfarin, a direct oral anticoagulant, or a combination of these drugs were taken during 484 scaling and root planing procedures, 218 implant placements, 53 open flap debridements, 16 gingival grafts, 15 lateral windows, and 71 other. Medications were continued in 99.6% of patients during the procedure. Postoperative bleeding occurred after three procedures (0.35%) and resolved with local hemostatic measures. Medications were temporarily discontinued in four instances (range 1-5 days); none of these patients experienced postoperative bleeding. Postoperative bleeding was infrequent in patients who underwent an invasive periodontal procedure while taking an antiplatelet or anticoagulant drug.

Identifiants

pubmed: 31103527
pii: S2212-4403(19)30461-4
doi: 10.1016/j.oooo.2019.04.005
pii:
doi:

Substances chimiques

Anticoagulants 0
Platelet Aggregation Inhibitors 0
Warfarin 5Q7ZVV76EI

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-249

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ryan T Rubino (RT)

Department of Oral Health Practice, College of Dentistry, University of Kentucky, Lexington, KY, USA.

Dolph R Dawson (DR)

Department of Oral Health Practice, College of Dentistry, University of Kentucky, Lexington, KY, USA.

Richard J Kryscio (RJ)

Department of Statistics, College of Arts & Sciences, University of Kentucky, Lexington, KY, USA.

Mohanad Al-Sabbagh (M)

Department of Oral Health Practice, College of Dentistry, University of Kentucky, Lexington, KY, USA.

Craig S Miller (CS)

Department of Oral Health Practice, College of Dentistry, University of Kentucky, Lexington, KY, USA. Electronic address: cmiller@uky.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH